Raise Money for Tonsil Cancer Treatment

PavelAndreev.ORG is an international crowdfunding platform for raising donations, through which thousands of charitable online campaigns have been organized. The platform is free for anyone who wants to start a campaign.

Start a campaign

How to start a tonsil cancer treatment fundraiser?

Your fundraiser on PavelAndreev.ORG starts in three quick and easy steps:

Create a campaign

Start your tonsil cancer treatment fundraising campaign in minutes with simple crowdfunding platform instructions.

Admin review & support

A platform administrator will review your tonsil cancer treatment campaign and help you prepare it in the best possible way.

Share & launch

Share your tonsil cancer treatment fundraising campaign on social media and receive donations from people who care.

Create a campaign

Start your tonsil cancer treatment fundraising campaign in minutes with simple crowdfunding platform instructions.

Admin review & support

A platform administrator will review your tonsil cancer treatment campaign and help you prepare it in the best possible way.

Share & launch

Share your tonsil cancer treatment fundraising campaign on social media and receive donations from people who care.

Start a campaign

Types of medical costs in tonsil cancer treatment

  • Pharmacotherapy and Systemic Therapy Expenses: Direct drug costs for chemotherapy agents (e.g., cisplatin, docetaxel, 5-fluorouracil, mitomycin), targeted biologics (e.g., cetuximab), immunotherapies (e.g., pembrolizumab, nivolumab, cemiplimab, ipilimumab), and novel bispecific antibodies (e.g., petosemtamab).
  • Diagnostic, Laboratory, and Staging Evaluation Expenses: Costs associated with tissue biopsies, histopathological confirmation, blood and organ/thyroid function monitoring, and radiological imaging modalities (CT, MRI, FDG-PET/CT).
  • Surgical Procedure Expenses: Facility and professional costs for surgical interventions, including primary tumor resections, transoral procedures, neck dissections, tracheostomies, and microvascular free-flap tissue reconstructions.
  • Radiation Oncology Expenses: Treatment costs related to external beam radiotherapy delivery, intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), proton therapy, and re-irradiation regimens.
  • Patient Insurance Cost-Sharing: Out-of-pocket expenses borne by patients, including insurance co-pays, deductibles, and co-insurance requirements for standard care or clinical trial procedures.

  • Diagnostic and Baseline Staging Phase: Expenditures for initial clinical evaluations, multidisciplinary consultations, baseline imaging, biopsy analysis, p16/HPV biomarker testing, and pre-anesthesia assessments.
  • Neoadjuvant and Induction Phase: Expenses for preliminary systemic therapy or induction chemotherapy regimens administered prior to primary locoregional therapy.
  • Primary / Definitive Treatment Phase: Major expenditure phase encompassing definitive surgery (e.g., upfront transoral robotic surgery) or definitive concurrent chemoradiotherapy.
  • Adjuvant and Post-Operative Phase: Costs for post-operative radiation therapy (PORT), post-operative chemoradiotherapy (POCRT), or risk-stratified de-escalated adjuvant regimens determined by surgical pathology.
  • Recurrent, Persistent, or Salvage Phase: Operational and clinical expenses for managing persistent or recurrent disease through salvage surgery, re-irradiation, or second- and third-line systemic therapies.

  • Regional and Institutional Setting Variations: Cost structure variations stemming from geographic location, health system type (tertiary academic research centers vs. community hospitals), and metropolitan versus non-metropolitan care delivery settings.
  • Patient Travel, Transportation, and Lodging: Non-medical indirect expenses incurred by patients and caregivers traveling for daily radiation fractions or specialized surgical care, including temporary patient lodging and transportation services.
  • Socioeconomic and Insurance Coverage Differences: Financial impacts related to payer categories (e.g., Medicare reimbursement schedules vs. private insurance plans), social vulnerability factors, and financial assistance programs.

  • Primary Tumor Subsite Treatment: Costs linked to the specific anatomical site of the primary lesion within the oropharynx, such as lateralized vs. non-lateralized palatine tonsil/tonsillar fossa resections, base of tongue resections, soft palate resections, or middle pharyngeal wall procedures.
  • Regional Lymph Nodal Management: Expenditures associated with unilateral versus bilateral neck dissection procedures, level-specific nodal irradiation, and neck level sparing protocols.
  • Tissue Reconstruction Donor Site Care: Surgical and recovery costs tied to tissue harvest sites for reconstructive free flaps, such as radial forearm free flaps (RFFF), anterolateral thigh flaps (ALTF), or latissimus dorsi flaps.
  • Anatomical Organs-at-Risk Protection and Complication Care: Costs associated with preserving or managing radiation-induced toxicity to critical structures, including the parotid and submandibular salivary glands, larynx, and pharyngeal constrictor muscles.

  • Minimally Invasive Surgical Technologies: Capital equipment, maintenance, and disposable costs associated with Transoral Robotic Surgery (TORS) platforms and Transoral Laser Microsurgery (TLM) instrumentation.
  • Advanced Radiotherapy Delivery: Expenses related to specialized radiation technology, including Intensity-Modulated Radiation Therapy (IMRT), image-guided radiotherapy (IGRT), proton therapy, and stereotactic boosts.
  • Targeted Biologics and Immunotherapy Innovations: Costs for innovative systemic agents, including anti-PD-1/PD-L1 immune checkpoint inhibitors, anti-EGFR targeted monoclonal antibodies, dual-targeting bispecific antibodies (e.g., EGFR x LGR5 petosemtamab), and therapeutic HPV vaccines.
  • Treatment De-Escalation Protocols: Strategic protocol expenses for de-intensified adjuvant chemoradiation regimens (such as reduced radiation dose to 30–50 Gy, mucosal-sparing radiation, or chemotherapy omission) designed to minimize long-term toxicity costs while maintaining cure rates.

  • Speech-Language and Swallowing Therapy: Expenses for baseline, post-operative, and long-term swallowing evaluations (videofluoroscopic swallowing studies [VFSS], modified barium swallows [MBS], fiberoptic endoscopic evaluations), swallow capacity testing, and pharyngeal strengthening exercises.
  • Enteral Nutrition and Feeding Tube Services: Costs for temporary or long-term enteral access procedures, including percutaneous endoscopic gastrostomy (PEG), nasogastric (NG), nasojejunal (NJ), or percutaneous endoscopic jejunostomy (PEJ) tube placement and maintenance, alongside specialized enteral formulas and dietitian counseling.
  • Oral, Dental, and Trismus Care: Costs for pre- and post-radiation dental extractions and care, xerostomia (dry mouth) management, and custom mouth-opening devices or physical therapy for trismus (jaw stiffness) rehabilitation.
  • Musculoskeletal and Lymphedema Therapy: Direct expenses for lymphatic decompression therapy, compression garments, and occupational or physical therapy for neck stiffness, fibrosis, or shoulder dysfunction following neck dissection.
  • Airway and Tracheostomy Care: Maintenance expenses for temporary or long-term tracheostomies, humidification supplies, respiratory therapy, and decannulation support services.

  • Inpatient Hospitalization and Bed-Day Costs: Hospital facility charges for post-surgical recovery, inpatient length of stay, and acute admissions required for management of severe complications (e.g., post-operative hemorrhage, pharyngocutaneous fistula, aspiration pneumonia, or osteomyelitis).
  • Surgical Suite and Operating Room Utilization: Facility fees associated with operating room time, robotic surgical equipment setup, specialized surgical nursing, and anesthesiology services.
  • Multidisciplinary Team Care Coordination: Administrative and clinical coordination costs for integrated multidisciplinary tumor boards involving head and neck surgeons, radiation oncologists, medical oncologists, speech-language pathologists, dietitians, social workers, and case managers.
  • Institutional Quality Assurance and Credentialing: Facility costs tied to surgical credentialing protocols, radiation quality assurance programs, and clinical trial operational administration.

  • Supportive Symptom Management: Costs for medical interventions focused on symptom palliation, including palliative radiation therapy for pain or bleeding control, management of severe mucositis and neuropathic pain, and antiemetic care.
  • Palliative Surgical Interventions: Surgical procedures performed specifically to alleviate severe treatment sequelae or incurable tumor involvement, such as palliative mandibulectomy for severe osteoradionecrosis, vascularized free-flap tissue coverage for tissue breakdown, or functional laryngectomy/pharyngoplasty for a non-functional, aspirating larynx.
  • Airway and Nutritional Palliation: Interventions for end-stage functional impairment, including palliative tracheostomy for acute airway obstruction and gastrostomy placement for severe dysphagia.
  • Hospice, Advance Care Planning, and Psychosocial Support: Expenses associated with advance care planning, social work, psychological counseling, distress management, and specialized hospice or end-of-life care services.

PavelAndreev.ORG results:

Donor trust and the security of funds on the platform are our highest priority. Be proactive. Start successful campaigns and raise donations! With PavelAndreev.ORG you can count on modern methods for receiving donations, a team that will be by your side throughout your campaign, security for your money, and 24/7 access to it.

Total you have donated

49.57M EUR

Regardless of its size, every donation helps save a human life or successfully carry out a social cause.

Total number of donations

1 497 541

The contribution of a large number of people reflects the commitment of our society and contributes to the success of the campaigns.

Number of active campaigns

665

Every campaign is a unique cause and offers an opportunity to bring about positive change in our society.

Be proactive. Start successful campaigns and raise donations! With PavelAndreev.ORG you can count on modern methods for receiving donations, a team that will be by your side throughout your campaign, security for your money, and 24/7 access to it.

Start a campaign

Three important reasons to start a campaign on PavelAndreev.ORG

At PavelAndreev.ORG we use new technologies to let you support fundraising campaigns quickly and easily.

Trust and security

To guarantee the security of funds, we use the most modern and proven service providers.

Easy & convenient donations

The platform supports multiple payment methods, through which people from all over the world can donate to your campaign.

Global audience

PavelAndreev.ORG is an international crowdfunding platform with a global audience of donors who want to support meaningful causes.

Trust and security

To guarantee the security of funds, we use the most modern and proven service providers.

Easy & convenient donations

The platform supports multiple payment methods, through which people from all over the world can donate to your campaign.

Global audience

PavelAndreev.ORG is an international crowdfunding platform with a global audience of donors who want to support meaningful causes.

Cancer statistics in the United States

Start a campaign
Start a campaign

PavelAndreev.ORG is a crowdfunding platform for organizing fundraising donation campaigns to raise money, managed by Foundation Pavel Andreev (UIC: 206678629) with founder and CEO Pavel Andreev. All donations made through the fundraising platform PavelAndreev.ORG are administered by the team of Pavel Andreev and the Foundation Pavel Andreev.

Google News: PavelAndreev.ORG, Pavel Andreev.